DoCM is proud to announce the launch of Empowering people with Cutaneous Leishmaniasis: Intervention Programme to improve patient journey and reduce Stigma via Community Education (ECLIPSE) in partnership with Keele University.
A cross-faculty research team from Keele University’s Institute for Global Health has received a major award of £4.6 million from the National Institute for Health Research (NIHR) to lead a global study investigating the social impact of a neglected tropical disease, cutaneous leishmaniasis.
The NIHR-funded study, called , is co-led by parasitologist Dr Helen Price and social anthropologist Dr Lisa Dikomitis from Keele University. ECLIPSE brings together researchers from four different continents and from a wide range of academic disciplines including anthropology, parasitology, primary care, applied health services, psychiatry, psychology, community engagement and public health.
The overall aim of ECLIPSE is to improve the patient journey for people living with cutaneous leishmaniasis and empower communities to deal with the devastating effects of stigma that it causes. The ECLIPSE team will be working in Brazil, Ethiopia and Sri Lanka and will contribute towards the World Health Organisation’s ambition of ensuring everyone has access to healthcare.
The Sri Lankan ECLIPSE team will be led by Prof.Suneth Agampodi. Prof. Nadira Karunaweera from University of Colombo and Dr.Hema Weerakoon from the Provincial Department of Health, North Central Province are also co-investigators of ECLIPSE Sri Lanka.
ECLIPSE is funded by the NIHR using UK aid from the UK Government under the NIHR Research and Innovation for Global Health Transformation (RIGHT) programme. ECLIPSE is one of the eight project funded by NIHR to support global health research on epilepsy, infection-related cancers and severe stigmatising skin diseases.
Read more about NIHR funded global health research projects to tackle epilepsy, infection-related cancers and severe stigmatising skin diseases in low- and middle-income countries (LMICs).